Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.920
+0.100 (2.07%)
At close: Nov 26, 2025, 4:00 PM EST
4.850
-0.070 (-1.42%)
After-hours: Nov 26, 2025, 7:59 PM EST
Annovis Bio Employees
As of December 31, 2024, Annovis Bio had 15 total employees, including 8 full-time and 7 part-time employees. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$1,658,963
Market Cap
130.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15 | -1 | -6.25% |
| Dec 31, 2023 | 16 | 11 | 220.00% |
| Dec 31, 2022 | 5 | 2 | 66.67% |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANVS News
- 3 days ago - Annovis Announces Two Presentations at the CTAD 2025 Conference - GlobeNewsWire
- 9 days ago - Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study - GlobeNewsWire
- 10 days ago - Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients - Benzinga
- 10 days ago - Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients - GlobeNewsWire
- 15 days ago - Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer's Program - GlobeNewsWire
- 4 weeks ago - Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules - GlobeNewsWire
- 6 weeks ago - Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock - GlobeNewsWire